For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world's most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HCV, HIV and Ebola. Copyright © 2009-2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Kenilworth, NJ, USA All rights reserved. This website is maintained by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and is intended for use by individuals who are not residents of the U.S. Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA This website of MSD & Co., Inc., Kenilworth, NJ, USA (the company) includes forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the companys management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Risks and uncertainties ...
| Website | http://www.msd-vietnam.com |
| Revenue | $15.1 million |
| Employees | 1 (1 on RocketReach) |
| Industry | Manufacturing General, Manufacturing |
| Competitors | iCeutica, ZeneXa Limited, Matrix Biomed (view competitors) |
| SIC | SIC Code 80 Companies, SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Merck Sharp & Dohme Ltd employee's phone or email?
The Merck Sharp & Dohme Ltd annual revenue was $15.1 million in 2026.
1 people are employed at Merck Sharp & Dohme Ltd.
The NAICS codes for Merck Sharp & Dohme Ltd are [325, 3254, 32].
The SIC codes for Merck Sharp & Dohme Ltd are [80, 283, 28].